Prominex, Inc., founded with a mission to revolutionize point-of-care infectious disease testing, is a leading biotechnology company based in the United States. The company's core vision is to provide rapid, accurate, and affordable molecular diagnostic assays that can deliver test results in minutes. Prominex's product offerings are designed to be easy-to-use, reusable, and scalable, making them accessible for a wide range of healthcare settings. Their primary market focus is on developing advanced diagnostic solutions for infectious diseases.
Notable achievements for Prominex include receiving funding from the NIH RADx® Tech program to advance their sample-to-answer molecular assay system. This recognition underscores their commitment to high-performance and accessible diagnostic testing. The company's innovative approach has positioned it as a significant player in the biotech industry, contributing to improved healthcare outcomes through faster and more reliable diagnostics.
